Hepatitis D: Clinical Trials

3 trials for Hepatitis D, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 unknown. 3 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 23Unknown 3

Follow Hepatitis D: new trials by email Literature Review of Hepatitis D trials Research Report on Hepatitis D

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study to Compare P1101 Plus TAF With or Without UDCA in Patients With HBV and HDV Co-Infection
Ursodeoxycholic acid, Ropeginterferon alfa-2b, Tenofovir Alafenamide - Hepatitis D
Phase 2UnknownNational Taiwan University Hospital302023-02-242022-12-29
Ezetimibe for Patients With Chronic Hepatitis D
Ezetimibe - Chronic Hepatitis D
Phase 2UnknownZiauddin Hospital202017-01-012017-04-04
Pegylated Interferon Alone or in Combination With Ezetimibe for Patients With Chronic Hepatitis D
Pegylated interferon alfa, Ezetimibe - Hepatitis D, Chronic
Phase 2UnknownAga Khan University202016-01-012017-04-07

Narrower conditions

Hepatitis D, Chronic (2)

Broader conditions

Digestive System Diseases (3)  ·  Hepatitis (3)  ·  Hepatitis, Viral, Human (3)  ·  Infections (3)  ·  Liver Diseases (3)  ·  RNA Virus Infections (3)  ·  Virus Diseases (3)  ·  Chronic Disease (2)  ·  Disease Attributes (2)  ·  Hepatitis, Chronic (2)  ·  Pathologic Processes (2)  ·  Pathological Conditions, Signs and Symptoms (2)

Interventions

Ezetimibe (2)  ·  Ursodeoxycholic Acid (1)  ·  tenofovir alafenamide (1)

Sponsors

Aga Khan University (1)  ·  National Taiwan University Hospital (1)  ·  Ziauddin Hospital (1)

Countries

Pakistan (1)  ·  Taiwan (1)

Top investigators

Pei-Jer Chen (1)